Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1Liver Neoplasms 1Liver Diseases 1Gastrointestinal Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1Carcinoma, Hepatocellular 1Adenocarcinoma 1

Interventions

Sorafenib 8Oxaliplatin 7Bevacizumab 6sintilimab 5lenvatinib 5apatinib 5Fluorouracil 5Capecitabine 5atezolizumab 4Leucovorin 4Folfox protocol 4camrelizumab 3Drug Therapy 3tremelimumab 2durvalumab 2Thalidomide 2Radiosurgery 2Nivolumab 2Neoadjuvant Therapy 2Injections 2Hepatectomy 2Gemcitabine 2Ethiodized Oil 2regorafenib 1pirarubicin 1pembrolizumab 1menatetrenone 1liposomal doxorubicin 1lanreotide 1halofantrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Carcinoma, Hepatocellular × Heparin, Low-Molecular-Weight × Clear all
NCT00827554 2016-04-01

The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

Eastern Hepatobiliary Surgery Hospital

Phase 2/3 Completed
100 enrolled
Gastrointestinal

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡